safflower seed-derived apolipoprotein A1 (SemBioSys)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namesafflower seed-derived apolipoprotein A1 (SemBioSys)
Drug Alias Nameapolipoprotein A1 (SemBioSys)plant-derived Apo A1 (SemBioSys)Apo AI (SemBioSys)Apo A1 (SemBioSys)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionApolipoprotein A-I stimulants
TargetsApolipoprotein A-I
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSemBioSys Genetics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSemBioSys Genetics Inc
Active IndicationsN/A
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A